Sign in
close
Username or email
*
Password
*
Log in
No account yet?
Create an Account
Search for:
Search
MICRO-IMMUNOTHERAPY
Low-dose immunotherapy
The immune system
Testimonials
Share your experience
Find your doctor
Clinics and health centers
Documents
Brochures for patients & general public
Scientific studies
THERAPEUTIC AREAS
OUR ACTIVITIES
Trainings and events
Join our Professional Area
Micro-immunotherapy in other languages
BLOG
Healthy lifestyle
Micro-immunotherapy news
Fields of application
ABOUT US
About us
Contact us
Cooperations
Micro-immunotherapy in other countries
AEMI
MEGEMIT
IFMI
PROFESSIONAL AREA
Shopping cart
close
DE
ES
FR
Professional Area
DE
ES
FR
close
Search for:
Search
Cart (
o
)
0
/
0,00
€
MICRO-IMMUNOTHERAPY
Low-dose immunotherapy
The immune system
Testimonials
Share your experience
Find your doctor
Clinics and health centers
Documents
Brochures for patients & general public
Scientific studies
THERAPEUTIC AREAS
OUR ACTIVITIES
Trainings and events
Join our Professional Area
Micro-immunotherapy in other languages
BLOG
Healthy lifestyle
Micro-immunotherapy news
Fields of application
ABOUT US
About us
Contact us
Cooperations
Micro-immunotherapy in other countries
AEMI
MEGEMIT
IFMI
Search for:
Search Button
Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV® Active Ingredients
Location:
WikiMi
Scientific Studies
Please login to see this content
Username or Email
Password
Remember Me
Forgot Password?
Join Us
Tags:
cytokines
EBV-associated diseases
Epstein-Barr virus
immunotherapy
interleukin-2
Micro-immunotherapy
Did you find it interesting?
Yes
0
No
Views:
100
Scroll To Top
